GREM1 and pancreatic neuroendocrine tumor: Consistent with its pro-angiogenic properties (i.e., via binding to VEGF-R2), Chen et al. [29] showed that Grem1 expression is associated with increased microvessel density, a marker of angiogenesis, in patients with pancreatic neuroendocrine tumors.